Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:activeIngredient |
lokivetmab
|
| gptkbp:administeredBy |
subcutaneous injection
|
| gptkbp:alternativeTo |
gptkb:Apoquel
|
| gptkbp:approvedBy |
gptkb:dog
gptkb:FDA 2016 |
| gptkbp:effect |
4 to 8 weeks
reduces itching |
| gptkbp:form |
injectable solution
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cytopoint
|
| gptkbp:manufacturer |
gptkb:Zoetis
|
| gptkbp:mechanismOfAction |
neutralizes IL-31 to reduce pruritus
|
| gptkbp:notRecommendedFor |
cats
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:sideEffect |
rare allergic reactions
mild injection site reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:target |
interleukin-31 (IL-31)
|
| gptkbp:usedFor |
treatment of atopic dermatitis in dogs
|
| gptkbp:bfsParent |
gptkb:Zoetis_Inc.
|
| gptkbp:bfsLayer |
7
|